Top Markets
Coin of the day
Spencer Pharmaceutical Inc. Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc.

SPPH
Rangering i aksjer #41284
Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms... Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms aimed at addressing neurological conditions. A core aspect of their expertise lies in the precise, controlled administration of existing therapeutic compounds for central nervous system disorders, such as Alzheimer's, Parkinson's disease, and various forms of brain cancer. Moreover, the company holds a proprietary slow-release drug delivery system, which is utilized for managing type-2 diabetes and arthritis, and holds promise for other medical applications. Its operations are predominantly located in North America and Europe. Spencer Pharmaceutical Inc. was established in 1998 and maintains its headquarters in Boston, Massachusetts.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$29.44K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Spencer Pharmaceutical Inc. (SPPH)

Kategori

P/S-forhold for Spencer Pharmaceutical Inc. (SPPH)
P/S-forhold per 2026 TTM: 0
Ifølge Spencer Pharmaceutical Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Spencer Pharmaceutical Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter